Last updated 2026-07-26
- Raised $5M Series A led by NFX Capital, Nov 2022
- Raised $7M Seed round led by NFX Capital, Mar 2022
Total raised
$12.0M
Last: Undisclosed Round 2022-12
Stage
Seed
Founded
2018
Headcount
15
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Pangea Biomed is an Israeli precision oncology biotech company that has developed ENLIGHT, an advanced multi-cancer, multi-therapy response predictor. The company's platform uses artificial intelligence and deep RNA analysis to map tumor molecular signatures, aiming to personalize cancer care, improve oncology drug development, and empower oncologists. Pangea Biomed's technology creates a “social graph” of genes and utilizes RNA-sequencing and machine learning to identify gene group interactions to determine a patient's best treatment match.
Funding history · 2 rounds · $12.0M total
2022-11
A Round
$5.0M
★ NFX Capital★ Danny Tocatly
2022-03
Seed
$7.0M
★ NFX Capital
Headcount over time
From 10 (2022-01) to 15 (2026-03) · +5 (+50%) · 23 points · source: Finder history + radar grounding
Q&A
- What is Pangea Biomed's primary focus?
- Pangea Biomed is a precision oncology biotech company that develops ENLIGHT, an advanced multi-cancer, multi-therapy response predictor using artificial intelligence and deep RNA analysis.
- When was Pangea Biomed founded?
- Pangea Biomed was founded in March 2018.
- How many employees does Pangea Biomed currently have?
- Pangea Biomed has 15 employees, falling within the 11-50 employee bucket.
- What is the total amount of funding Pangea Biomed has raised to date?
- Pangea Biomed has raised a total of $12,000,000 in funding.
- When did Pangea Biomed secure its most recent funding?
- Pangea Biomed secured a Seed round of $5,000,000 in December 2022, with Danny Tocatly as a lead investor.
- Which investors participated in Pangea Biomed's Seed round in April 2022?
- In April 2022, Pangea Biomed raised $7,000,000 in a Seed round, with NFX.
- What technologies does Pangea Biomed utilize in its platform?
- Pangea Biomed utilizes Artificial Intelligence and Machine Learning in its platform.
- Who are the co-founders of Pangea Biomed?
- The co-founders of Pangea Biomed are Eyal Gottlieb, Ze'ev Ronai, and Eytan Ruppin.
Team · 3
Eyal Gottlieb
Founder · Co-founder
Ze'ev Ronai
Founder · Co-founder
Eytan Ruppin
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Highlights
Verified
Tags
actionable-insightsbiotechnologyprecision-medicinetreatmentsoncologyartificial-intelligencetargeted-therapypharma-companiesdigital-healthcaredecision-supportmachine-learningimmunotherapycancerdrug-discoverylaboratoriespersonalizationclinical-trials
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | pangeabiomed.com/ |
|---|---|
| linkedin.com/company/71201409 | |
| YouTube | youtube.com/channel/UC0tgNPLez863ZMHRGrs-HyQ |
Identifiers & details
| Former names | Pangea Therapeutics |
|---|---|
| Founded | 2018-3 |
| Employees (exact) | 15 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
Web history (Wayback)
| Domain | pangeabiomed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 48 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515823839 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-03-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 3 — shares_capital (1), people (2) |
| Registered address | הברזל 2א תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-07 | הקצאת מניות |
| 2026-05-06 | עדכון דירקטורים-הסרת דירקטור |
| 2025-12-02 | עדכון דירקטורים-הוספת דירקטור |